The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the effect of vitamin D supplementation (alone or with co-supplementation) on insulin resistance in patients with polycystic ovary syndrome (PCOS). Methods: We performed a literature search of databases (Medline, Scopus, Web of Knowledge, Cochrane Library) and identified all reports of randomized controlled trials (RCTs) published prior to April 2018. We compared the effects of supplementation with vitamin D alone (dose from 1000 IU/d to 60,000 IU/week) or with co-supplements to the administration of placebos in women diagnosed with PCOS. The systematic review and meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (Prospero) as number CRD42018090572. Main results: Eleven of 345 identified studies were included in the analysis; these involved 601women diagnosed with PCOS. Vitamin D as a co-supplement was found to significantly decrease fasting glucose concentrations and the HOMA-IR value. HOMA-IR also declined significantly when vitamin D was supplemented with a dose lower than 4000 IU/d. Conclusions: Evidence from RCTs suggests that the supplementation of PCOS patients with continuous low doses of vitamin D (<4000 IU/d) or supplementation with vitamin D as a co-supplement may improve insulin sensitivity in terms of the fasting glucose concentration (supplementation with vitamin D in combination with other micronutrients) and HOMA-IR (supplementation with vitamin D in continuous low daily doses or as co-supplement).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
Jørgensen, L., Paludan-Müller, A. S., Laursen, D. R. T., Savović, J., Boutron, I., Sterne, J. A. C., Higgins, J. P. T., & Hróbjartsson, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0259-8 · Cited by 396
Sempos, C. T., Heijboer, A. C., Bikle, D. D., Bollerslev, J., Bouillon, R., Brannon, P. M., DeLuca, H. F., Jones, G., Munns, C. F., Bilezikian, J. P., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13652 · Cited by 331
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
Kung, J., & Henry, R. R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.691963 · Cited by 198 · cited 1×
“However, it has been observed that metformin is also often poorly tolerated because of gastrointestinal side effects, such as nausea (61%), vomiting (30%), and diarrhea (65%) [9,10].”
BackgroundKaramali, M., Ashrafi, M., Razavi, M., Jamilian, M., Akbari, M., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104530 · Cited by 34 · cited 4×
“[19], 2018 Cholecalciferol + calcium + vitamin K Placebo SG PG 23.”
BackgroundInfluential
Cited by
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Xing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review
Menichini, D., & Facchinetti, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1625881 · Cited by 73
“[22] 20,000 IU/w 24 Increased 25hydroxyvitamin D Decreased PG after 60min during OGTT, No changes in HbA1c, HOMA-IR, QUICKI No changes in cholesterol and TG No changes of total and free-testosterone, Increased menstrual regularity [21] 50,000 IU/w 8 Increased 25hydroxyvitamin D Decreased FPG, serum insulin levels, HOM…”
BackgroundResultInfluentialMenichini, D., Forte, G., Orrù, B., Gullo, G., Unfer, V., & Facchinetti, F. (2022) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000691 · Cited by 56
Saadati, N., Haidari, F., Barati, M., Nikbakht, R., Mirmomeni, G., & Rahim, F. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08338 · Cited by 34
“So far several meta-analyses have assessed the effect of nutritional intervention on many aspects of PCOS such as insulin resistance [16, 17, 18, 19, 20, 21], Biochemical parameters [22, 23, 24], and androgenic profiles [25, 26].”
Metadata
- Authors
- Łagowska, K., Bajerska, J., & Jamka, M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-11-02
- Volume
- 10
- Issue
- 11
- Pages
- 1637
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2899140719
- Cited by
- 112
- References
- 8
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.